Equillium Inc (EQ)
1.57
+0.03
(+1.95%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Equillium Total Liabilities (Quarterly): 22.50M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 22.50M |
| December 31, 2023 | 27.96M |
| September 30, 2023 | 31.12M |
| June 30, 2023 | 31.78M |
| March 31, 2023 | 42.52M |
| December 31, 2022 | 46.48M |
| September 30, 2022 | 20.47M |
| June 30, 2022 | 22.20M |
| March 31, 2022 | 21.60M |
| December 31, 2021 | 18.90M |
| September 30, 2021 | 16.67M |
| June 30, 2021 | 15.06M |
| Date | Value |
|---|---|
| March 31, 2021 | 14.96M |
| December 31, 2020 | 15.57M |
| September 30, 2020 | 14.26M |
| June 30, 2020 | 13.29M |
| March 31, 2020 | 13.56M |
| December 31, 2019 | 13.69M |
| September 30, 2019 | 14.04M |
| June 30, 2019 | 3.825M |
| March 31, 2019 | 3.233M |
| December 31, 2018 | 2.228M |
| September 30, 2018 | 16.80M |
| June 30, 2018 | 0.5891M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.825M
Minimum
Jun 2019
46.48M
Maximum
Dec 2022
21.02M
Average
17.78M
Median
Total Liabilities (Quarterly) Benchmarks
| Janux Therapeutics Inc | 33.22M |
| Mersana Therapeutics Inc | 170.39M |
| Vera Therapeutics Inc | 65.81M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.60M |
| Shareholders Equity (Quarterly) | 21.09M |
| Current Ratio | 1.913 |
| Net Debt Paydown Yield | 2.20% |